Jmd Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 33 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.95 M
- Revenue Growth 6.71%
- Profit Growth -14.97%
- Ebitda -7.19%
- Net Worth 3.87%
- Total Assets 32.59%
About Jmd Pharmaceuticals
Jmd Pharmaceuticals Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 1991 and has a history of 33 years and 11 months. Its registered office is in Bareilly, Uttar Pradesh, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.95 M.
Raj Kumar, Arjun Sharma, and Vinod Kumar serve as directors at the Company.
Company Details
-
Location
Bareilly, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231UP1991PTC012763
-
Company No.
012763
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Feb 1991
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Jmd Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Kumar
|
Director | 20-Aug-2010 | Current |
|
Arjun Sharma
|
Director | 20-Aug-2010 | Current |
|
Vinod Kumar
|
Director | 20-Aug-2010 | Current |
Financial Performance of Jmd Pharmaceuticals.
Jmd Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.71% increase. The company also saw a substantial fall in profitability, with a 14.97% decrease in profit. The company's net worth moved up by a moderate rise of 3.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jmd Pharmaceuticals?
In 2023, Jmd Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.95 M
₹0
Charges Breakdown by Lending Institutions
- Bareilly Corporation Bank : 0.20 Cr
- Up Financial Corporation : 0.10 Cr
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 1998 | Bareilly Corporation Bank | ₹2.00 M | Open |
| 18 May 1994 | State Bank Of India | ₹0.95 M | Open |
| 30 Sep 1991 | Up Financial Corporation | ₹0.72 M | Open |
| 30 Sep 1991 | Up Financial Corporation | ₹0.28 M | Open |
How Many Employees Work at Jmd Pharmaceuticals?
Unlock and access historical data on people associated with Jmd Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmd Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmd Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
